Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Smaroula Dilioglou, Ph.D., D(AHBI)

Smaroula Dilioglou, Ph.D., D(AHBI)


Smaroula Dilioglou, Ph.D., D(AHBI)

Smaroula Dilioglou, Ph.D., D(AHBI)

Assistant Member
The Methodist Hospital Research Institute
Associate Director of HLA
Department of Pathology and Genomic Medicine
The Methodist Hospital

E-mail: sdilioglou@houstonmethodist.org
Phone: 713-441-4757
Fax: 713-441-1565


B.S.   Belhaven College, Jackson, MS (Biology)
M.S.   University of Mississippi Medical Center, Jackson, MS (Immunology)
Ph.D.   University of Mississippi Medical Center, Jackson, MS

Postdoctoral Training

Postdoctoral Research Associate, Department of Immunology, St. Jude´s Children´s Research Hospital, Memphis, TN



After completing her postdoctoral training in 2004, Dr. Dilioglou remained at St. Jude´s and worked as a technician in the HLA Laboratory. While there, she also worked as an independent CHT contractor at the Mid-South Transplant Foundation. At the University of Mississippi Medical Center in 2002, Dr. Dilioglou received the Robert A. Mafrey Jr. Memorial Award for Research Potential in Immunology. She assumed her current positions at The Methodist Hospital and Methodist Hospital Research Institute in 2007.

Description of Research

Dr. Dilioglou´s research focuses on various areas of immunology, including immune function in spinal cord injury patients, costimulatory function of dendritic cells, retroviral vectors, and macrophage function.

Major Areas of Research

Islet immunogenicity, HLA DP antibodies, dendritic cells.

Recent Publications

Szymczak A, Workman CJ, Gill D, Dilioglou S, Vignali KM, Palmer E, Vignali DAA. The CD3a prolinerich sequence, and its interaction Nck, is not required for T cell development and function. J Immuno 175:270-275, 2005.

Cruse JM, Lewis R, Dilioglou S. Effects of tumor-enhancing IgG2 on macrophage function. Exp Mol Pathol 77(1):43-48, 2004.

Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, Vignali DAA. Correction of multi-gene deficiency in vivo using a single ´self-cleaving´ 2A peptide-based retroviral vector. Nature Biotechnol 22:589-94, 2004.

Dilioglou S, Cruse JM, Lewis RE. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells. Exp Mol Pathol 75:18-33, 2003. Cruse JM, Wang H, Lewis RE, C

Cruse JM, Wang H, Lewis RE, Cespedes JC, Morrison RS, Lineaweaver WC, Dilioglou S. Cellular and molecular alterations in spinal cord injury patients with pressure ulcers: a preliminary report. Exp Mol Pathol 72:124-131, 2002.